Evidence map›Paper›PMID 32786797›Full record

ArticleJournal of the American Chemical Society2020

Modular Approaches to Lankacidin Antibiotics.

Lingchao Cai, Yanmin Yao, Seul Ki Yeon, Ian B Seiple

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the American Chemical Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of systematic and evolutionary microbiology · 2024
    Article
  4. Article
  5. International journal of systematic and evolutionary microbiology · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Lingchao CaiJiangsu Provincial Key Lab for the Chemistry and Utilization of Agro-Forest Biomass, Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Jinagsu Key Lab of Biomass-Based Green Fuels and Chemicals, Nanjing Forestry University, Nanjing, 210037 Jiangsu, China.
Yanmin YaoDepartment of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94158, United States.
Seul Ki YeonDepartment of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94158, United States.
Ian B SeipleDepartment of Pharmaceutical Chemistry and Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94158, United States.ORCID 0000-0002-8732-1362
University of California, San Francisco · USNanjing Forestry University · CN

Funding

Platforms for the Synthesis of Bacterial Protein Synthesis InhibitorsR35GM128656 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SEIPLE, IAN BASS · 2018 to 2022
$2.1M
NIGMS NIH HHS R35 GM128656
6 · The paper itself

Abstract

Lankacidins are a class of polyketide natural products isolated from

Indexed as

Anti-Bacterial AgentsBacillus subtilisCrystallography, X-RayMacrolidesMicrobial Sensitivity TestsMicrococcusModels, MolecularMolecular StructureStaphylococcus aureusStereoisomerismStreptomycesAnti-Bacterial AgentslankacidinsMacrolides

Identifiers

PMID32786797
PMCPMC8193914
OpenAlexW3046791602

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.